You are currently viewing Artificial Intelligence In Pathology Market 13.2% CAGR Outlook: Size, Segments And Regional Analysis
Artificial Intelligence In Pathology Market Analysis

The Business Research Company’s 2026 market reports combine market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights to deliver research that is more actionable and strategically valuable.

Is The Artificial Intelligence In Pathology Market Expanding? Latest Size Estimates And 2030 Projections

The artificial intelligence in pathology market has witnessed rapid expansion in recent years. It is forecast to grow from $1.38 billion in 2025 to $1.57 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.4%. The historical growth in this market can be attributed to increasing digitization of pathology workflows, rising demand for accurate cancer diagnostics, the expansion of pharmaceutical research activities, the adoption of digital slide scanners, and the growing availability of medical imaging datasets.

The artificial intelligence in pathology market is set for significant growth in the coming years, with its size projected to reach $2.57 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.2%. This expansion during the forecast period is largely attributable to the increasing application of AI-assisted diagnostics, a heightened focus on personalized medicine, the broader integration of AI in clinical decision support, rising investments in digital healthcare infrastructure, and a growing number of regulatory approvals for AI-based pathology tools. Major trends anticipated over this period include the wider adoption of AI-based digital pathology platforms, increased utilization of deep learning for tumor detection, enhanced integration of whole slide imaging systems, the expansion of predictive analytics in disease diagnosis, and a stronger emphasis on workflow automation within pathology laboratories.

Free Artificial Intelligence In Pathology Market Sample: Market Size, Growth Drivers And Competitive Landscape:

https://thebusinessresearchcompany.com/sample_request?id=55228934&type=smp&name=Artificial%20Intelligence%20In%20Pathology%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Artificial Intelligence In Pathology Market Drivers Explained: What Is Supporting A 13.2% CAGR?

The growing demand for personalized medicine is projected to propel the expansion of the artificial intelligence in pathology market in the coming years. Personalized medicine refers to the practice of tailoring medical care and treatment to the individual characteristics, needs, and preferences of each patient. The heightened need for personalized medicine arises from its capacity to customize treatments according to individual genetic profiles, lifestyle factors, and specific disease characteristics, thereby enhancing efficacy and reducing adverse reactions. Artificial intelligence (AI) in pathology supports personalized medicine by enabling more accurate and efficient analysis of medical images and genetic data, which facilitates more precise diagnoses, better identification of disease subtypes, and the development of tailored treatment plans aligned with an individual’s unique biological profile. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based professional membership organization, reported that in 2023, the US Food and Drug Administration (FDA) approved 20 new personalized medicines. This accounted for approximately 38% of all newly approved therapeutic molecular entities, marking a significant increase compared to previous years. Therefore, the increasing need for personalized medicine is a key factor driving the growth of the artificial intelligence in pathology market.

Artificial Intelligence In Pathology Market Segment Guide: Main Divisions And Subsegments

The artificial intelligence in pathology market covered in this report is segmented –

1) By Component: Software, Scanners

2) By Neural Network: Generative Adversarial Networks, Convolutional Neural Networks, Conventional Neural Network, Recurrent Neural Networks, Other Neural Networks

3) By Application: Drug Discovery, Disease Diagnosis And Prognosis, Clinical Workflow, Training And Education

4) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Reference Laboratories, Academic And Research Institutes

Subsegments:

1) By Software: Image Analysis Software, Diagnostic Workflow Software, Predictive Analytics Software

2) By Scanners: Whole Slide Imaging Scanners, Digital Pathology Scanners, Multi-Spectral Imaging Scanners

Artificial Intelligence In Pathology Market Trends And Opportunities For 2026–2030

Major companies operating within the artificial intelligence (AI) in pathology market are concentrating on developing sophisticated solutions, including multi-tissue cancer identification tools, to boost diagnostic precision, optimize operational processes, and improve patient outcomes. These AI-powered multi-tissue cancer detection tools utilize foundation models and deep-learning algorithms to examine digital pathology slides, enabling detection across various tissue types, encompassing uncommon tumors and metastatic deposits. For instance, in January 2024, Paige, a US-based digital pathology company, introduced a new AI application. Built upon its Virchow foundation model, this application is capable of identifying cancer across more than 17 different tissue types. The solution is designed to support pathologists by providing enhanced diagnostic accuracy, more efficient workflow, and practical insights for tailored patient care.

Which Major Players Are Active In The Artificial Intelligence In Pathology Market?

Major companies operating in the artificial intelligence in pathology market are F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Hamamatsu Photonics K.K., Leica Biosystems, Tempus Labs Inc., Spectra AB, Lunit Inc., Paige AI Inc., Inspirata Inc., Indica Labs Inc., Flagship Biosciences Inc, Proscia Inc., Aiforia Technologies Oy, Lumea Inc., Optrascan Inc., PathAI Inc., Visiopharm A/S, Ibex Medical Analytics Ltd., BioSymetrics Inc., Deep Bio Inc., Konfoong Biotech International Co Ltd., Mindpeak GmbH, Qritive Inc., Vuno Inc.

Unlock The Complete Artificial Intelligence In Pathology Market Report With Company Benchmarking:

https://thebusinessresearchcompany.com/report/artificial-intelligence-in-pathology-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Artificial Intelligence In Pathology Market World Regions Compared: Which Leads In Revenue?

Asia-Pacific was the largest region in the artificial intelligence in pathology market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in pathology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model